Beacle
- Company typePrivate
- Founded2002
- HeadquartersKyoto, Japan
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
Beacle firmographics
Firmographics- Name
- Beacle
- Legal name
- Beacle, Inc.
- Website
- https://beacle.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Ownership category
- akta.pro rank
Beacle industry classification
Industry- Product category
- Biotechnology Research Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industry
- Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
Keywords
Where Beacle is headquartered
LocationHeadquarters
- HQ city
- Kyoto
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
Beacle business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Research Reagents Sales: Sale of research reagents including immune assay products (Western blot, ELISA), HBV-related products, and SARS-CoV-2 related products. Revenue from product sales through direct channels and distributors.
- Research Services: Contract research services including protein production using E. coli and yeast, DDS formulation, ELISA construction, pharmacological studies, and custom immunoassay development. Services priced from ¥200,000 to ¥1,500,000+ depending on complexity.
- Medicinal Technology Development: Development of medicinal technologies based on BNC platform including DDS, vaccines, and antibody sensors. Long-term development requiring significant resources, funded partially by research reagent business.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | HBsAg L-protein (Recombinant) - 100μg |
| Unit Pricing | Pay-as-you-go | HBV ELISA Kits - 96 assay kit |
| Unit Pricing | Pay-as-you-go | Antibody-binding BNC products |
| Unit Pricing | Pay-as-you-go | HBV Antibodies - 100μg |
| Unit Pricing | Multi-year contract | Research Services - various |
| Unit Pricing | Pay-as-you-go | SARS-CoV-2 Products |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Beacle product offering
Product offeringCore offering
Beacle develops and manufactures biological research reagents including Western blot kits, ELISA kits, HBV antigens and antibodies, SARS-CoV-2 antigens, and signal enhancers, built on its proprietary Bionanocapsule (BNC) technology. The company also offers contract research services including protein production, drug delivery system (DDS) formulation, and custom immunoassay construction for pharmaceutical companies, universities, and research institutions.
Product overview
Beacle is a biotechnology company that develops and manufactures biological reagents and research services based on its proprietary Bionanocapsule (BNC) technology. The company's product portfolio includes research reagents for immune assays (Western blot and ELISA), HBV-related products (antigens, antibodies, and ELISA kits), SARS-COV-2 research reagents, and research services including DDS formulation, protein production, and custom immunoassay construction. The core technology platform is the Bionanocapsule - a nano-sized hollow particle derived from HBV surface protein that enables drug delivery, antibody sensing, and vaccine applications. Products are organized into apparatus (Auto Western), ELISA construction kits (Easy ELISA Constructor), Western blot reagents (Signal Boosters, blocking solutions, markers), ELISA kits (HBV and SARS-COV-2), recombinant antigens and antibodies, MAD detection reagents, and contract research services.
Differentiator
Problem solved
Functional benefit
Products and services
- Easy ELISA Constructor (ab) and Easy ELISA Constructor Multi (ab) Kit to construct antibody-detecting ELISA and evaluate antibody titer within 90 minutes using proprietary MAD technology, available in standard and multi-format versions for immunology researchers.
- Easy-WESTERN-II and Easy-WESTERN Multi Western blot kits using HRP-labeled MAD reagent for highly sensitive or rapid (1 hour) detection without a secondary antibody; multi-channel version supports simultaneous multi-protein detection.
- HRP Stabilizer
Quantifiable outcome
- Detection sensitivity improved by 100-fold compared to conventional secondary antibody methods
- +3 more outcomes
Companies that use Beacle
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Beacle technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature9 records
Beacle partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and major.
- AMED (Japan Agency for Medical Research and Development)coreAMED selected Beacle's project 'Development of next-generation intranasal therapeutic vaccine HBNET-369 for radical cure of hepatitis B' for their hepatitis practical application research program. This supports Beacle's vaccine development using novel HBV antigen technology.
- NEDO (New Energy and Industrial Technology Development Organization)coreBeacle was selected for NEDO's 2014 Innovation Practical Application Development Project, supporting their technology development efforts.
- B-Bridge InternationalmajorInternational distribution partner handling Beacle's HBV ELISA kits and research reagents in USA and Europe markets.
- Takara-BiomajorDistribution partner for Beacle products in Japan.
- CosmobiomajorDistribution partner for Beacle products in Japan.
- FunakoshimajorDistribution partner for Beacle products in Japan.
Scale indicators5 records
Recent moves8 records
Expansion highlights5 records
Beacle competitors and assessment
Company assessmentDirect peers
- Funakoshi: Japanese distributor of molecular and cell biology reagents. Acts as a Beacle distribution partner while also carrying comparable HBV, immunology and protein research reagent lines from competing manufacturers.
- Takara Bio: Japanese life-science reagent and tools company with overlapping HBV-related and protein research reagent catalogs. Beacle uses Takara-Bio as a distributor, but the two also compete head-to-head in molecular biology and immunology reagents sold to Japanese researchers.
- Cosmobio: Japanese life-science reagent distributor and manufacturer. Both distributes Beacle products and offers competing reagent lines for Western blot, ELISA and protein research to the Japanese academic market.
- MBL (Medical & Biological Laboratories): Japanese specialty reagent company focused on immunology, autoimmune and infectious-disease assay reagents. Closely comparable to Beacle in HBV and immunology ELISA reagent offerings to academic and pharma researchers in Japan.
Broad incumbents
- Abcam: Global research antibody and immunoassay reagent supplier. Overlaps with Beacle in HBV antibodies, ELISA kits and broader immunoassay reagents, though at vastly greater scale and catalog breadth.
- Cell Signaling Technology: Major US-based antibody and immunoassay reagent company. Competes with Beacle in high-sensitivity Western blot and ELISA detection chemistries across academic and pharma research customers.
- Wako Pure Chemical Industries (FUJIFILM Wako): Large Japanese reagent manufacturer offering a deep catalog of biochemical, immunological and clinical-diagnostics reagents. Overlaps with Beacle in ELISA kits, blocking solutions and HBV-related antigens.
- Bio-Rad Laboratories: Large global life-science research tools company with broad Western blot, ELISA and protein detection reagent lines. Competes with Beacle's MAD-based detection reagents and HBV ELISA kits across most research segments.
Regional players
- B-Bridge International: US-headquartered distributor of Japanese life-science reagents. Acts as Beacle's primary channel into North America and Europe for HBV ELISA kits and specialty detection reagents.
Emerging players
- GenScript: Global biotech offering gene synthesis, protein production and antibody services. Comparable to Beacle's protein production and DDS formulation research services, with overlapping pharma and academic customers.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Beacle compliance and trust
Trust signalCompliance1 record
Beacle financial estimates
Financial estimateRevenue estimate
Valuation estimate
Beacle leadership team
Management profileNumber of profiles
Profiles1 record
Beacle funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Beacle M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Beacle
What does Beacle do?
Beacle develops and manufactures biological research reagents including Western blot kits, ELISA kits, HBV antigens and antibodies, SARS-CoV-2 antigens, and signal enhancers, built on its proprietary Bionanocapsule (BNC) technology. The company also offers contract research services including protein production, drug delivery system (DDS) formulation, and custom immunoassay construction for pharmaceutical companies, universities, and research institutions.
Is Beacle a public or private company?
Beacle is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Beacle founded?
Beacle was founded in 2002.
Where is Beacle based?
Beacle is headquartered in Kyoto, Japan, in the Asia region.
How does Beacle make money?
Three revenue lines are on record. Research Reagents Sales are the primary driver. The others are research Services and medicinal Technology Development.
Who are Beacle's main competitors?
Direct peers on record are Funakoshi, Takara Bio, Cosmobio and MBL (Medical & Biological Laboratories). Broad incumbents are Abcam, Cell Signaling Technology, Wako Pure Chemical Industries (FUJIFILM Wako) and Bio-Rad Laboratories. B-Bridge International is listed as a regional player. GenScript is listed as an emerging player.
Does Beacle have an API?
No public API is recorded for Beacle.
What industry is Beacle in?
Beacle's product category is Biotechnology Research Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls). Its NAICS code is 325413 and its SIC code is 2835.